Topics

Human medicines European public assessment report (EPAR): Zonisamide Mylan, zonisamide, Epilepsy, Date of authorisation: 31/03/2016, Revision: 3, Status: Authorised

07:20 EDT 1 Oct 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Zonisamide Mylan, zonisamide, Epilepsy, Date of authorisation: 31/03/2016, Revision: 3, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Zonisamide Mylan, zonisamide, Epilepsy, Date of authorisation: 31/03/2016, Revision: 3, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Zonisamide Mylan, zonisamide, Epilepsy, Date of authorisation: 31/03/2016, Revision: 3, Status: Authorised"

Quick Search

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...